To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
Sponsor: Rep. Bilirakis, Gus M. (R-FL)5 cosponsorsIntroduced Sep 14, 2026
✆
In plain English
Rep. Gus Bilirakis (R-FL) sponsored this bill to make permanent the authority for the Secretary of Health and Human Services to award priority review vouchers for drugs and biologics developed to treat rare pediatric diseases. Priority review vouchers speed up FDA approval timelines for certain medications. The bill extends this authority indefinitely, whereas current law allows it to expire.
One email when they vote against their own party. Nothing else.
Nonpartisan · Unsubscribe in one click · We never sell your address
Track this bill
Get an alert when it moves to the next stage or gets a vote.
Share
Embed this tracker on your site
Paste this HTML into your blog post or website to show a live tracker for this bill.
The embedded card updates automatically as the bill progresses. Preview →
See something wrong on this page? Tell us what looks incorrect and what it should be — we’ll investigate and correct it.
Report incorrect information
Every figure on this site is supposed to trace back to an official source. If something
here is wrong, telling me is the fastest way it gets fixed — and corrections are
published.